Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglolysis GM 1mg/500mg/0.3mg Tablet

Prescription Icon
Prescription Required

Marketer

Jrb Lifesciences Private Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglolysis GM 1mg/500mg/0.3mg Tablet

Diabetics using Voglolysis GM (1mg/500mg/0.3mg) tablets, an anti-diabetic combination medication, manage type 2 diabetes mellitus. This medication regulates blood glucose in adults. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Voglolysis GM 1mg/500mg/0.3mg Tablet

Managing type 2 diabetes

Major Benefits of Voglolysis GM 1mg/500mg/0.3mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Voglolysis GM 1mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this tablet on an empty stomach.

Common Side effects of Voglolysis GM 1mg/500mg/0.3mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglolysis GM 1mg/500mg/0.3mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Voglolysis GM 1mg/500mg/0.3mg tablets should be taken on an empty stomach.

How Voglolysis GM 1mg/500mg/0.3mg Tablet works:

Each Voglolysis GM tablet (1mg/500mg/0.3mg) contains a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Voglolysis GM 1mg/500mg/0.3mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnant individuals should exercise caution with Voglolysis GM 1mg/500mg/0.3mg Tablets, as limited human data and adverse animal reproductive study results suggest potential harm to the fetus. A physician will assess the risk-benefit profile before prescribing this medication. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Voglolysis GM 1mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Voglolysis GM 1mg/500mg/0.3mg Tablets due to potential safety concerns. Medical advice is recommended. Furthermore, this medication is not advised for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Voglolysis GM 1mg/500mg/0.3mg tablets cautiously, potentially requiring dose modification. Consult a physician before use. For individuals with mild to moderate hepatic dysfunction, initiation with a reduced dosage is typical; however, it's contraindicated in those with severe liver disease.

What if you forget to take Voglolysis GM 1mg/500mg/0.3mg Tablet :

Should you forget a Voglolysis GM 1mg/500mg/0.3mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglolysis GM 1mg/500mg/0.3mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglolysis GM 1mg/500mg/0.3mg Tablet

Voglolysis GM, a combination tablet containing glimepiride, metformin, and voglibose, treats type 2 diabetes mellitus in adults. It improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Voglolysis GM 1mg/500mg/0.3mg Tablets may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste perception, flatulence, abdominal pain, headache, skin rash, and respiratory infections.
Voglolysis GM 1mg/500mg/0.3mg Tablets are contraindicated in patients allergic to any component or excipient. This medication should also be avoided in those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Voglolysis GM 1mg/500mg/0.3mg tablets with alcohol is unsafe. This combination may worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Voglolysis GM 1mg/500mg/0.3mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Store this medication in its original, tightly sealed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Voglolysis GM 1mg/500mg/0...
106
MRP 129
17% off